{
  "meta": {
    "title": "Mid_Day_Module_Obg-2",
    "url": "https://brainandscalpel.vercel.app/mid-day-module-obg-2-b28d97d7.html",
    "scrapedAt": "2025-11-29T18:15:37.412Z"
  },
  "questions": [
    {
      "id": 13348,
      "choices": [
        {
          "id": 53353,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">≥ 110 mg/dl</span></p>"
        },
        {
          "id": 53354,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">≥ 126 mg/dl</span></p>"
        },
        {
          "id": 53355,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">≥ 140 mg/dl</span></p>"
        },
        {
          "id": 53356,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">≥ 200 mg/dl</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">For diagnosis of overt gestational diabetes, the fasting blood sugar (FBS] level should be?</span></p>",
      "unique_key": "Q5608824",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590770,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B. ≥ 126 mg/dl&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">IADPSG Recommendations: Testing in 2 phases</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>1<sup>st</sup> Phase: To test for overt diabetes (which the woman may be unaware of)</strong></span><br>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Done in the 1<sup>st</sup> trimester (early antenatal visit)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Test using HbA1C/ FBS/ RBS</span></li><li><span style=\"color:black;font-size:12.0pt;\">FBS ≥ 126 mg/dL</span></li><li><span style=\"color:black;font-size:12.0pt;\">HbA1C ≥ 6.5 %</span></li><li><span style=\"color:black;font-size:12.0pt;\">RBS ≥ 200 mg/dL (but this should be confirmed by FBS/ HbA1C)</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-200643.jpg\" alt=\"\" width=\"39\" height=\"58\"></span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>2<sup>nd</sup> Phase: To test for GDM</strong></span><br>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Done between 24 – 28 weeks</span></li><li><span style=\"color:black;font-size:12.0pt;\">75g GTT</span></li><li><span style=\"color:black;font-size:12.0pt;\">Fasting: 92/ 1h – 180/ 2h – 153</span></li><li><span style=\"color:black;font-size:12.0pt;\">Any one value abnormal: Enough to diagnose GDM</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">To diagnose overt gestational diabetes, the fasting blood sugar (FBS) level should be ≥ 126 mg/dl (milligrams per decilitre).</span></li><li><span style=\"font-size:12pt;\">It's important to note that the diagnostic criteria for gestational diabetes may vary in different guidelines and regions. However, a fasting blood sugar level of ≥ 126 mg/dl is a commonly recognized threshold for diagnosing overt gestational diabetes.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xKRl68F.png\" width=\"1265\" height=\"844\"></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Ref: Page 1108, Williams Obstetrics 25<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53354,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13311,
      "choices": [
        {
          "id": 53205,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Deep tendon reflexes, urine output, Respiratory rate</span></span></span></p>"
        },
        {
          "id": 53206,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Deep tendon reflexes, O2 saturation, consciousness status</span></span></span></p>"
        },
        {
          "id": 53207,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">O2 saturation, urine output, heart rate</span></span></span></p>"
        },
        {
          "id": 53208,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heart rate, BP, respiratory rate&nbsp;and urine output</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 20-year primi presented at 32 weeks with eclampsia. She was started on MgSO4 (Pritchard&rsquo;s regime) and she delivered after induction of labor. Maintenance dose of MgSO4 was continued for 24 hours. Prevention of Mg toxicity involves monitoring of the following clinical parameters: </span></span></span></p>",
      "unique_key": "Q6804477",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590787,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Deep tendon reflexes, urine output, Respiratory rate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A woman on MgSO4 for management of eclampsia requires the following to be checked for Mg toxicity:</span></span></span>\r\n\r\n\t<ol>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Deep tendon reflexes</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Respiratory Rate</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urine Output</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Magnesium toxicity</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">At &gt; 7-10 mEq/L: Loss of DTR</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">10 - 12 mEq/L: Respiratory depression</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">25 mEq/L: Cardiac arrest</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Antidote: Ca gluconate (1 g IV)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The prevention of magnesium toxicity in the management of eclampsia involves careful monitoring of deep tendon reflexes, urine output, and respiratory rate. Deep tendon reflexes help detect early signs of toxicity, urine output indicates renal function and magnesium clearance, and respiratory rate assesses potential respiratory depression from magnesium sulfate. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1<sup>st</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 53205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13341,
      "choices": [
        {
          "id": 53325,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">a, b, c</span></p>"
        },
        {
          "id": 53326,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">a, d, e</span></p>"
        },
        {
          "id": 53327,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">a, b</span></p>"
        },
        {
          "id": 53328,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">a, b, c, d&nbsp;&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are feature(s) of magnesium toxicity in pregnancy?</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Loss of deep tendon reflex</span></li><li><span style=\"font-size:12.0pt;\">Decreased respiratory rate</span></li><li><span style=\"font-size:12.0pt;\">Decreased urine output</span></li><li><span style=\"font-size:12.0pt;\">Hypertension</span></li><li><span style=\"font-size:12.0pt;\">Increased heart rate</span></li></ol>",
      "unique_key": "Q1353259",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590763,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. a, b</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Features of Mg Toxicity are</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Loss of deep tendon reflex (Depression of patellar reflex is the earliest sign of patellar toxicity): Earliest Sign</span></li><li><span style=\"font-size:12.0pt;\">Decreased respiratory rate (&lt;12 per minute)</span></li><li><span style=\"font-size:12.0pt;\">Chest pain, heart block, pulmonary edema</span></li><li><span style=\"font-size:12.0pt;\">Cardiac arrest</span></li><li><span style=\"font-size:12.0pt;\">O<sub>2</sub> saturation monitoring (PaO2 &lt; 95%)</span></li><li><span style=\"font-size:12.0pt;\">Double vision</span></li><li><span style=\"font-size:12.0pt;\">Slurred speech</span></li><li><span style=\"font-size:12.0pt;\">Nausea-vomiting</span></li><li><span style=\"font-size:12.0pt;\">Muscular weakness</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>**Decreased urine output is not a feature of Mg toxicity. Renal failure can be seen in severe preeclampsia/ eclampsia and as Mg is excreted through the kidneys, decreased renal function can increase the Mg levels in the blood thereby leading to Mg toxicity.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus Option C) is correct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Features of Magnesium Toxicity:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Loss of deep tendon reflex (Depression of patellar reflex is the earliest sign of patellar toxicity): Earliest Sign</span></li><li><span style=\"font-size:12.0pt;\">Decreased respiratory rate (&lt;12 per minute)</span></li><li><span style=\"font-size:12.0pt;\">Chest pain, heart block, pulmonary edema</span></li><li><span style=\"font-size:12.0pt;\">Cardiac arrest</span></li><li><span style=\"font-size:12.0pt;\">O<sub>2</sub> saturation monitoring (PaO2 &lt; 95%)</span></li><li><span style=\"font-size:12.0pt;\">Double vision</span></li><li><span style=\"font-size:12.0pt;\">Slurred speech</span></li><li><span style=\"font-size:12.0pt;\">Nausea-vomiting</span></li><li><span style=\"font-size:12.0pt;\">Muscular weakness</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">**Decreased urine output is not a feature of Mg toxicity. Renal failure can be seen in severe preeclampsia/ eclampsia and as Mg is excreted through the kidneys, decreased renal function can increase the Mg levels in the blood thereby leading to Mg toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 1880, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53327,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13364,
      "choices": [
        {
          "id": 53417,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Necrotizing enterocolitis</span></span></span></span></p>"
        },
        {
          "id": 53418,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hyperbilirubinemia</span></span></span></span></p>"
        },
        {
          "id": 53419,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Neonatal hypocalcemia</span></span></span></span></p>"
        },
        {
          "id": 53420,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Neonatal hyperglycemia</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 32-years old G3P2L2 visits an antenatal clinic at 28 weeks. She reveals during history that her first baby weighed 4.6 kg, second baby weighed 4.8 kg, and both were delivered by C-section. Neonatal complications of an infant of diabetic mother except?</span></span></span></p>",
      "unique_key": "Q8470673",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590781,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. D.&nbsp; Neonatal hyperglycemia</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Diabetes mellitus during pregnancy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Neonatal complications (Seen because of Pedersen Hypothesis)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypoglycemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Respiratory distress syndrome</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hyperbilirubinemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Necrotizing enterocolitis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Polycythemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypocalcemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypomagnesemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Cardiomyopathy</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s discuss the neonatal complications associated with infants of diabetic mothers, to understand why &quot;Neonatal hyperglycemia&quot; is the exception:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Necrotizing Enterocolitis (Option A)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While not the most common complication in infants of diabetic mothers, necrotizing enterocolitis (NEC) can occur. NEC is a serious intestinal disease that affects mostly premature infants. Infants of diabetic mothers are at risk for various complications, but NEC is not typically a direct consequence of maternal diabetes.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperbilirubinemia (Option B)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a common complication in infants of diabetic mothers. These infants often have increased red blood cell turnover, which can lead to higher levels of bilirubin and result in jaundice.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neonatal Hypocalcaemia (Option C)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Infants of diabetic mothers are at an increased risk of hypocalcemia, or low calcium levels in the blood. This can occur due to various metabolic imbalances associated with the maternal diabetic environment.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neonatal Hyperglycemia (Answer D)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is less likely in infants of diabetic mothers and thus is the correct answer. In fact, neonatal hypoglycemia is a more common issue in these infants. Due to high insulin levels in response to maternal hyperglycemia, these infants can have low blood sugar levels after birth once the maternal glucose supply is cut off.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Neonatal complications (Seen because of Pedersen Hypothesis)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypoglycemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Respiratory distress syndrome</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hyperbilirubinemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Necrotizing enterocolitis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Polycythemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypocalcemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypomagnesemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Cardiomyopathy</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:&nbsp;</span></span></span></em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Page no 1102, Williams Obstetrics 25<sup>th</sup> edition</span></span></span></strong></p>",
      "correct_choice_id": 53420,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13355,
      "choices": [
        {
          "id": 53381,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Caudal regression syndrome is a commonly associated anomaly seen in diabetes</span></p>"
        },
        {
          "id": 53382,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">The risk of anomalies in the fetus is inversely proportional to the level of HBA1c.</span></p>"
        },
        {
          "id": 53383,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Folic acid in a dose of 5 mg/day started in the preconception period will not reduce the risk of neural tube defects.</span></p>"
        },
        {
          "id": 53384,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Metformin and Glyburide can be safely continued in pregnancy even though they cross the placenta.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">A 36-year diabetic woman on insulin is planning conception. She is worried about the risk of fetal congenital anomalies and visits for preconception counseling. Which of the following is the correct statement?</span></p>",
      "unique_key": "Q7929872",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590775,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D. Metformin and Glyburide can be safely continued in pregnancy even though they cross the placenta.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">The most common anomaly in diabetic mothers is congenital heart disease</span></li><li><span style=\"color:black;font-size:12.0pt;\">The most specific (albeit rare) anomaly in diabetic mothers is caudal regression syndrome (mermaid syndrome)</span></li><li><span style=\"color:black;font-size:12.0pt;\">The higher the HBA1C level preconceptionally; the higher the risk of fetal anomalies</span></li><li><span style=\"color:black;font-size:12.0pt;\">Both metformin and glyburide cross the placenta but evidence has shown they are safe</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Let's analyse each option:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Caudal Regression Syndrome is Commonly Associated with Diabetes</strong>: Caudal regression syndrome, a rare disorder characterized by abnormal development of the lower spine, is indeed more common in infants born to mothers with pre-existing diabetes, particularly those with poor glycemic control. However, it's important to note that while the risk is increased, the condition itself is still relatively rare.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Risk of Anomalies Inversely Proportional to HbA1c Levels</strong>: This statement is partially true. Higher HbA1c levels, indicating poorer blood sugar control, are associated with an increased risk of congenital anomalies. However, this option is slightly misleading as it implies a direct inverse proportionality, which is an oversimplification. The relationship between HbA1c and risk is significant, but other factors also play a role.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Folic Acid at 5 mg/day Will Not Reduce Risk of Neural Tube Defects</strong>: This statement is incorrect. Folic acid supplementation, typically at a dose of 400-800 micrograms per day, is known to reduce the risk of neural tube defects. In some cases, such as in women with a history of a child with a neural tube defect or those on certain medications like antiepileptics, a higher dose like 5 mg/day might be recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Metformin and Glyburide Safe in Pregnancy (Answer D)</strong>: Metformin and glyburide are oral hypoglycemic agents that can indeed cross the placenta. However, current evidence suggests that they are safe to use during pregnancy and are often prescribed to manage gestational diabetes or pre-existing diabetes in pregnant women. This is the correct statement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">While higher HbA1c levels are associated with increased risks, the use of certain oral hypoglycemic agents like metformin and glyburide is considered safe during pregnancy.</span></li><li><span style=\"font-size:12pt;\">Additionally, folic acid supplementation is important for reducing the risk of neural tube defects.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Ref:&nbsp; Page no 1110, Williams Obstetrics 25<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53384,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30496,
      "choices": [
        {
          "id": 121862,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elective cesarean delivery regardless of the presence of lesions at the time of labor</span></span></p>"
        },
        {
          "id": 121863,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginal delivery if there are no active lesions at the time of labor</span></span></p>"
        },
        {
          "id": 121864,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginal delivery with administration of antiviral prophylaxis</span></span></p>"
        },
        {
          "id": 121865,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Induction of labor at 37 weeks to reduce the risk of neonatal infection</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A pregnant woman is diagnosed with primary genital herpes infection. What is the most appropriate management regarding delivery?</span></span></span></p>",
      "unique_key": "Q4668838",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590765,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Vaginal delivery if there are no active lesions at the time of labor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: If a woman has primary genital herpes before pregnancy or in early pregnancy and has no active lesions at the time of labor, vaginal delivery is usually safe. However, if she has active genital lesions or prodromal symptoms at the onset of labor, a cesarean delivery is recommended to prevent neonatal herpes infection<strong>.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If there is active genital herpes at term, cesarean section has to be done </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 673, High Risk Pregnancy: Management Options; David James, Philip J Steer; 5<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 121863,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13415,
      "choices": [
        {
          "id": 53621,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">6-10 weeks</span></span></span></span></p>"
        },
        {
          "id": 53622,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">12-20 weeks</span></span></span></span></p>"
        },
        {
          "id": 53623,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">24-28 weeks</span></span></span></span></p>"
        },
        {
          "id": 53624,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">36 &ndash; 40 weeks</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The highest risk of developing congenital varicella syndrome is? </span></span></span></p>",
      "unique_key": "Q8846765",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590782,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B. 12-20 weeks</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Congenital Varicella Syndrome is characterized by</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chorioretinitis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Microphthalmia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cerebral cortical atrophy</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fetal growth restriction</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydronephrosis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Limb hypoplasia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cicatricial skin lesions</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The highest risk of fetal infection is between 13-20 weeks.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 1212-1213, Williams Obstetrics 25<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 53622,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13360,
      "choices": [
        {
          "id": 53401,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &ge; 126 mg/dL</span></span></span></span></p>"
        },
        {
          "id": 53402,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">PPBS &ge; 140 mg/dl</span></span></span></span></p>"
        },
        {
          "id": 53403,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">HbA1C &ge; 6.5 %</span></span></span></span></p>"
        },
        {
          "id": 53404,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">RBS &ge; 200 mg/dL</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">As per IADPSG recommendations, pre-gestational diabetes is diagnosed in the 1<sup>st</sup> antenatal visit by all of the values given below except?</span></span></span></p>",
      "unique_key": "Q7406735",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590777,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B. PPBS &ge; 140 mg/dl</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">IADPSG Recommendations: Testing in 2 phases</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">1<sup>st</sup> Phase: To test for overt diabetes (which the woman may be unaware of)</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Done in the 1<sup>st</sup> trimester (early antenatal visit)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Test using HbA1C/ FBS/ RBS</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">FBS &ge; 126 mg/dL</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HbA1C &ge; 6.5 %</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RBS &ge; 200 mg/dL (but this should be confirmed by FBS/ HbA1C)</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">2<sup>nd</sup> Phase: To test for GDM </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Done between 24 &ndash; 28 weeks</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">75g GTT</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fasting: 92/ 1h &ndash; 180/ 2h &ndash; 153</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Any one value abnormal: Enough to diagnose GDM</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In diagnosing pre-gestational diabetes during the first antenatal visit, IADPSG guidelines include criteria such as a fasting blood sugar of &ge; 126 mg/dL, an HbA1c of &ge; 6.5%, or a random blood sugar of &ge; 200 mg/dL. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;Ref: Page 1108, Williams Obstetrics 25<sup>th</sup> edition</span></span></span></strong></p>",
      "correct_choice_id": 53402,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13350,
      "choices": [
        {
          "id": 53361,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">34 weeks</span></span></span></span></p>"
        },
        {
          "id": 53362,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">37 weeks</span></span></span></span></p>"
        },
        {
          "id": 53363,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">38 weeks</span></span></span></span></p>"
        },
        {
          "id": 53364,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">40 weeks</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 34-year Primi who is a known diabetic on insulin presents at 34 weeks pregnancy.&nbsp; On examination, the uterus is 34 weeks and FHR is 140 bpm. Her blood sugar is well controlled. At what period of gestation should her delivery be planned? </span></span></span></p>",
      "unique_key": "Q3958894",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590771,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. C. 38 weeks</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">In Overt Diabetes&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">(Pre-gestational diabetes) on insulin, Plan delivery at 38 weeks OR earlier if </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Poorly controlled sugars</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Non reassuring fetal status</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">In Gestational Diabetes</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Plan delivery at 40 weeks </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Avoid past dates</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Anticipate shoulder dystocia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Prophylactic LSCS in diabetic women if estimated fetal weight &gt; 4.5 Kg</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">In Overt Diabetes (Pre-gestational diabetes) on insulin, delivery is planned at 38 weeks.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Earlier delivery may be planned if there are poorly controlled sugars or non-reassuring fetal status</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 1107, Williams Obstetrics, Page no 509, Textbook of Obstetrics by JB Dutta</span></span></span></strong></p>",
      "correct_choice_id": 53363,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13346,
      "choices": [
        {
          "id": 53345,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Anemia</span></span></span></p>"
        },
        {
          "id": 53346,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Antepartum hemorrhage</span></span></span></span></p>"
        },
        {
          "id": 53347,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gestational Diabetes mellitus</span></span></span></span></p>"
        },
        {
          "id": 53348,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Thrombocytopenia</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">An infant was born at 36 weeks of pregnancy with a birthweight 4.5 kg as shown in the image.&nbsp; Which of the following conditions is associated with this presentation?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/picture13_fMnCKOd.jpg\" style=\"height:169px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q9293144",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590767,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. C. Gestational Diabetes mellitus</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The clinical scenario shown is of macrosomia. </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Macrosomia is defined as estimated fetal weight &gt; 90<sup>th</sup> percentile for that gestational age</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Causes of macrosomia are.</span></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gestational Diabetes mellitus</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Maternal obesity</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Previous baby with macrosomia</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Post-term pregnancy</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Excessive weight gain in pregnancy</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Anemia and APH are associated with fetal growth restriction</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Thrombocytopenia has no association with fetal weight</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let&#39;s briefly explain each option:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Anemia</span></strong><span style=\"font-size:12.0pt\">: Anemia refers to a deficiency of hemoglobin in the blood and is not typically associated with macrosomia or a large birthweight.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Antepartum hemorrhage</span></strong><span style=\"font-size:12.0pt\">: Antepartum hemorrhage refers to bleeding during pregnancy before the onset of labor and is not directly associated with the infant&#39;s birthweight.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Gestational Diabetes Mellitus (GDM)</span></strong><span style=\"font-size:12.0pt\">: Infants born to mothers with GDM are at an increased risk of macrosomia, which can have implications for both mother and baby. Proper management of GDM during pregnancy is essential to reduce the risk of complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Thrombocytopenia</span></strong><span style=\"font-size:12.0pt\">: Thrombocytopenia is a condition characterized by a low platelet count in the blood and is not directly related to the infant&#39;s birthweight.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The birth of an infant with a birthweight of 4.5 kg at 36 weeks of pregnancy is suggestive of macrosomia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Macrosomia is commonly associated with maternal gestational diabetes mellitus (GDM), which can lead to larger birthweights in babies.</span></span></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 53347,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13357,
      "choices": [
        {
          "id": 53389,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">It is done in the fasting state</span></p>"
        },
        {
          "id": 53390,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Patients with a positive GCT are subjected to a GTT (Glucose tolerance test)</span></p>"
        },
        {
          "id": 53391,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">The lower the threshold taken in a GCT, the higher the sensitivity for detection of gestational diabetes mellitus</span></p>"
        },
        {
          "id": 53392,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">It is done between 24 – 28 weeks</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">A 23-year primigravida presents to the OPD at 24 weeks. She is advised to get a Glucose Challenge Test done. All are true regarding the glucose challenge test (GCT) except?</span></p>",
      "unique_key": "Q3569891",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590776,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A. It is done in the fasting state.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Glucose Challenge Test (GCT)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Done at 24 – 28 weeks.</span></li><li><span style=\"font-size:16px;\">Plasma glucose is measured 1 h after a 50g glucose load irrespective of prandial state.</span></li><li><span style=\"font-size:16px;\">Value of&nbsp;</span><ul><li><span style=\"font-size:16px;\">≥ 140 mg/ dl: screen positive: subjected to glucose tolerance test (GTT)</span></li><li><span style=\"font-size:16px;\">≥ 200: Diagnosed as GDM (No need for GTT)</span></li><li><span style=\"font-size:16px;\">The lower the threshold of GCT, the higher the sensitivity and lower the specificity for detecting gestational diabetes.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Let's evaluate the options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. It is done in the fasting state (Answer A)</strong>: This statement is incorrect, and therefore the answer. The GCT is a non-fasting test. The pregnant woman is given a glucose solution to drink, and her blood sugar level is tested after one hour. The fasting state is not required for this test, distinguishing it from the Glucose Tolerance Test (GTT).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Patients with a positive GCT are subjected to a GTT&nbsp;</strong></span><span style=\"background-color:transparent;font-size:16px;\"> <strong>(glucose tolerance test)</strong></span><span style=\"font-size:16px;\">: This statement is correct. If the GCT results are positive or above a certain threshold, it suggests the possibility of gestational diabetes, and the patient is then advised to undergo a GTT for confirmation. The GTT is a more comprehensive test involving fasting and multiple blood sugar measurements over a few hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. The lower the threshold in a GCT, the higher the sensitivity for detection of GDM</strong>: This is also correct. Lowering the threshold level for GCT results means more women will be classified as having a positive screen, increasing the sensitivity of the test. However, this might also lead to a higher false-positive rate, where women without GDM are identified as potentially having it.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. It is done between 24 – 28 weeks</strong>: This is a true statement. The GCT is typically performed between 24 and 28 weeks of gestation. This timing is chosen because gestational diabetes usually develops around this period in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">The Glucose Challenge Test is a non-fasting, initial screening test for gestational diabetes conducted between 24 to 28 weeks of pregnancy.</span></li><li><span style=\"font-size:16px;\">A positive GCT necessitates further testing with a Glucose Tolerance Test. Adjusting the threshold level of the GCT can impact its sensitivity and specificity for detecting gestational diabetes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Page no 262, DC Dutta's Textbook of Obstetrics 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53389,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13345,
      "choices": [
        {
          "id": 53341,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">The patient has diabetes</span></p>"
        },
        {
          "id": 53342,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">The patient has a urine infection</span></p>"
        },
        {
          "id": 53343,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">The patient’s urinalysis is consistent with normal pregnancy</span></p>"
        },
        {
          "id": 53344,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">The patient’s urine sample is contaminated.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">During a routine antenatal visit, an 24-year G1 at 20 weeks gestational age undergoes a urinalysis. The dipstick done indicates the presence of glycosuria. All other parameters of the urine test are normal. Which of the following is the most likely etiology of sugar detected in the urine?</span></p>",
      "unique_key": "Q9145408",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590766,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C. The patient’s urinalysis is consistent with normal pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">In pregnancy, the increased GFR and the impaired tubular reabsorption capacity for filtered glucose occurs; hence glycosuria is a normal finding in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Let's explain each of the options :</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. The patient has diabetes:</strong> Glycosuria is a potential indicator of diabetes, but not a diagnostic of GDM and further diagnostic tests like fasting blood sugar (FBS), oral glucose tolerance test (OGTT), or HbA1c may be required to confirm the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. The patient has a urine infection</strong>: Urinary tract infections (UTIs) can sometimes cause glycosuria due to the presence of bacteria in the urinary tract that can ferment glucose, leading to its appearance in the urine. If a urine infection is suspected, further tests such as a urine culture and sensitivity should be performed to confirm the presence of infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The patient’s urinalysis is consistent with normal pregnancy</strong>: During pregnancy, some women may develop mild glycosuria as a normal physiological response to hormonal changes. This is known as \"physiological glycosuria\" and is not associated with diabetes or other medical conditions. It is a benign condition in pregnancy and does not necessarily indicate diabetes. It typically resolves after pregnancy. Monitoring blood glucose levels may still be advisable to rule out diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. The patient’s urine sample is contaminated:</strong> Contamination of the urine sample with glucose-containing substances (e.g., vaginal secretions) can lead to false-positive results for glycosuria. Careful collection and handling of urine samples are essential to ensure accurate test results. Contamination should be minimized to obtain reliable urinalysis results.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Physiological glycosuria, a normal response to hormonal changes in pregnancy, may lead to the presence of glucose in the urine without underlying diabetes.<strong> </strong>It is essential to consider other factors, such as diabetes, urinary tract infections, and sample contamination, and perform further tests if necessary to determine the cause of glycosuria.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Ref: Page 66, William’s Obstetrics 25<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53343,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13352,
      "choices": [
        {
          "id": 53369,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pre-gestational diabetes</span></span></span></span></p>"
        },
        {
          "id": 53370,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gestational diabetes mellitus</span></span></span></span></p>"
        },
        {
          "id": 53371,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Effect of valproate</span></span></span></span></p>"
        },
        {
          "id": 53372,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypertensive on ACE inhibitors</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Identify the maternal condition that can lead to the findings in the baby as shown below</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/picture14_kY8nI7M.jpg\" style=\"height:307px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q2368660",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590772,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A. Pre-gestational diabetes</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">This image is mermaid syndrome or sirenomelia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It is characteristically associated with overt (pre-gestational) Diabetes mellitus.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The most common anomaly associated with overt (pre-gestational) diabetes mellitus in pregnancy is cardiac anomalies (VSD being the most common).</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s examine each of the options:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pre-gestational Diabetes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This refers to diabetes that exists before pregnancy. Women with pre-gestational diabetes have a higher risk of giving birth to babies with congenital anomalies, including neural tube defects and cardiovascular malformations.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational Diabetes Mellitus (GDM)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This type of diabetes develops during pregnancy and generally resolves after delivery. While GDM can lead to several complications, such as macrosomia or hypoglycemia in the baby, it is not typically associated with congenital anomalies.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Effect of Valproate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Valproate use during pregnancy, particularly in the first trimester, is associated with an increased risk of several congenital malformations, including neural tube defects, cleft palate, and heart defects.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertensive on ACE Inhibitors</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: ACE inhibitors are not recommended during pregnancy, as they can lead to fetal complications such as renal damage. However, there is no known association between the use of ACE inhibitors and sirenomelia.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mermaid syndrome or sirenomelia is characteristically associated with overt (pre-gestational) Diabetes mellitus.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most common anomaly associated with pre-gestational diabetes mellitus in pregnancy is cardiac anomalies (VSD being the most common).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page 1110, Williams Obstetrics 25<sup>th</sup> edition</span></span></span></strong></p>",
      "correct_choice_id": 53369,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13419,
      "choices": [
        {
          "id": 53637,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">CMV</span></span></span></span></p>"
        },
        {
          "id": 53638,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">HPV</span></span></span></span></p>"
        },
        {
          "id": 53639,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Rubella</span></span></span></span></p>"
        },
        {
          "id": 53640,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Tetanus</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">A 25 y woman is planning to conceive. She is unsure of her childhood vaccination status. Which of the following vaccines should she receive before conceiving? </span></span></span></span></p>",
      "unique_key": "Q7375443",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590783,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. C. Rubella</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pre-pregnancy, if rubella immunization status Is unknown, serological evaluation is done (IgG rubella) and if IgG Rubella is negative, then vaccination with rubella vaccine is recommended. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Very important! Conception is to be avoided for 1 month after vaccination with rubella as it is a live attenuated vaccine</span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 647, High Risk Pregnancy: Management Options; David James, Philip J Steer; 5<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 53639,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30500,
      "choices": [
        {
          "id": 121878,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute fatty liver of pregnancy</span></span></span></p>"
        },
        {
          "id": 121879,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HELLP syndrome</span></span></p>"
        },
        {
          "id": 121880,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intrahepatic cholestasis of pregnancy</span></span></p>"
        },
        {
          "id": 121881,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute viral hepatitis</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A pregnant woman in her second trimester presents with mildly elevated liver enzymes and itching over her body. She has no history of liver disease. What is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q8828382",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590768,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Intrahepatic cholestasis of pregnancy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Intrahepatic cholestasis of pregnancy typically presents in the second or third trimester with itching and elevated liver enzymes but without significant liver damage. It&#39;s characterized by impaired bile flow and can lead to adverse fetal outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A: Acute Fatty Liver of Pregnancy: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is diagnosed by the Swansea criteria. Patients with AFLP usually present in the 3<sup>rd</sup> trimester with jaundice, abdominal pain, vomiting. There is altered liver function along with worsening renal and coagulation parameters. Hypoglycemia is typically seen. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B: HELLP Syndrome: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a form of severe preeclampsia so a h/o high BP would usually be mentioned. HELLP syndrome is a triad of <strong>H</strong>emolysis, <strong>E</strong>levated <strong>L</strong>iver Enzymes and <strong>L</strong>ow <strong>P</strong>latelets. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D: Acute viral hepatitis: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This can be seen in any trimester. There is a history of fever, constitutional symptoms and jaundice. Serum bilirubin is raised and AST and ALT are very highly raised. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-125402.jpg\" style=\"height:458px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Reference- Page no 270, DC Dutta&rsquo;s textbook of Obstetrics, 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 121880,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13427,
      "choices": [
        {
          "id": 53669,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Malaria</span></span></span></span></p>"
        },
        {
          "id": 53670,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Parvovirus </span></span></span></span></p>"
        },
        {
          "id": 53671,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Rubella</span></span></span></span></p>"
        },
        {
          "id": 53672,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Varicella</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Which of the following infections can cause fetal hydrops?</span></span></span></span></p>",
      "unique_key": "Q5142175",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590785,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B. Parvovirus</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Parvovirus B19 infects rapidly dividing cells</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It is cytotoxic for erythroid progenitor cells</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Parvovirus B19 infections in pregnancy can causes fetal anemia, hydrops and fetal death especially if infection happens within 20 weeks of pregnancy</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 654, High Risk Pregnancy: Management Options; David James, Philip J Steer; 5<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 53670,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13343,
      "choices": [
        {
          "id": 53333,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &amp; PPBS</span></span></span></span></p>"
        },
        {
          "id": 53334,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">HBA1C</span></span></span></span></p>"
        },
        {
          "id": 53335,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Urine routine for sugar</span></span></span></span></p>"
        },
        {
          "id": 53336,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">GCT</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 34-year Primigravida presents to the antenatal OPD. Her mother is a diabetic and she is screened for Diabetes at her 8 weeks antenatal visit. What was the most likely screening method used?</span></span></span></p>",
      "unique_key": "Q3747682",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590764,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. HBA1C</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">As per IADPSG guidelines, testing for Diabetes in the first trimester of pregnancy is by HBA1c or an FBS or RBS. &nbsp;(For Overt diabetes Hba1C &gt; 6.5 % or FBS &gt;126 mg/dl or RBS &gt;200 mg/dl)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Urine for sugar is not sensitive for testing for Diabetes in pregnancy as physiologic glycosuria can be present</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GCT is not used for Diabetes screening in the first trimester. It is part of screening of GDM between 24 &ndash; 28 weeks. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let&#39;s look at each option separately :</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. FBS &amp; PPBS:</span></strong><span style=\"font-size:12.0pt\"> FBS and PPBS are essential for monitoring blood sugar levels in pregnant women, but both together may typically be performed later in pregnancy or when there is suspicion of gestational diabetes. IADPSG Consensus Panel members favored use of any available certified laboratory measure of glucose (Fasting OR Random plasma glucose OR Hb A1C) for initial detection of possible cases. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. HBA1C (Hemoglobin A1C)</span></strong><span style=\"font-size:12.0pt\">: HBA1C is a blood test that provides an average of a person&#39;s blood sugar levels over the past two to three months. It is a valuable screening tool for diabetes, including in pregnant women. HBA1C can be used as an early screening method for diabetes in pregnant women, especially when there is a family history of diabetes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Urine Routine for Sugar</span></strong><span style=\"font-size:12.0pt\">: Urine routine for sugar is not the primary method for diabetes screening in pregnant women. It may be used for general monitoring but is less reliable than blood tests.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. GCT (Glucose Challenge Test)</span></strong><span style=\"font-size:12.0pt\">: GCT is typically performed later in pregnancy to screen for gestational diabetes and is not the primary method for early screening in the first trimester.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective (Summary): </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemoglobin A1C (HBA1C) is the most likely screening method used for diabetes at the 8-week antenatal visit, especially when there is a family history of diabetes. It provides a longer-term view of blood sugar control.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 1108, Williams Obstetrics 25<sup>th</sup> edition</span></span></strong></p>",
      "correct_choice_id": 53334,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13362,
      "choices": [
        {
          "id": 53409,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Glyburide</span></span></span></span></p>"
        },
        {
          "id": 53410,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Insulin</span></span></span></span></p>"
        },
        {
          "id": 53411,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Metformin</span></span></span></span></p>"
        },
        {
          "id": 53412,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pioglitazone</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Which hypoglycemic drug cannot be used in diabetes in pregnancy?</span></span></span></span></p>",
      "unique_key": "Q7657796",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590779,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. D. Pioglitazone</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Drugs safe in pregnancy are:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">OHA &ndash; Metformin (Category B) and Glyburide (Category C) and Insulin</span></span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Both Metformin and Glyburide cross the placenta</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Metformin: </span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Biguanide, acts by promoting glucose uptake in the periphery and the liver</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Suppresses hepatic glucose production</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypoglycemia not seen</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Started at 250 mg TDs; Max: 2500 mg/day</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Glyburide</span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases insulin secretion</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Safe after 15 weeks</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dose: 2.5 mg BD; may 20 mg/ day</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased incidence of neonatal and maternal hypoglycemia with glyburide</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s discuss each option:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glyburide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Glyburide is a sulfonylurea class of medication that increases insulin secretion from the pancreas. It is classified as Category C by the FDA, meaning that animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks. Glyburide does cross the placenta but has been used in pregnancy, particularly in the second and third trimesters. However, it may increase the risk of neonatal and maternal hypoglycemia.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Insulin is the most common and preferred treatment for managing diabetes in pregnancy, especially if the diabetes is pre-gestational. It does not cross the placenta and therefore does not pose a direct risk to the fetal development. Different types of insulin can be used to manage blood sugar levels effectively during pregnancy.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Metformin is a biguanide that decreases hepatic glucose production and increases glucose uptake in the periphery. Classified as Category B by the FDA, it suggests that there is no evidence of risk in human pregnancy. Metformin does cross the placenta, but studies have not shown an increased risk of birth defects or other pregnancy complications. It&#39;s often used in gestational diabetes and in women with polycystic ovary syndrome (PCOS) who are trying to conceive.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone (Answer D)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pioglitazone belongs to the thiazolidinedione class of drugs, which is generally not recommended during pregnancy. The safety of pioglitazone in pregnancy has not been established, and there are concerns about its potential effects on the fetus. Therefore, it is usually avoided in pregnancy.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When treating diabetes in pregnancy, insulin is the preferred medication due to its safety profile.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin and glyburide can also be used, albeit with some caution and monitoring.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone, on the other hand, is not recommended for use during pregnancy due to the lack of sufficient safety data and potential fetal risks.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 1110, Williams Obstetrics 25<sup>th</sup> edition</span></span></span></strong></p>",
      "correct_choice_id": 53412,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13351,
      "choices": [
        {
          "id": 53365,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Insulin secretion increases in pregnancy</span></span></span></span></p>"
        },
        {
          "id": 53366,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Insulin resistance is due to placental hormones</span></span></span></span></p>"
        },
        {
          "id": 53367,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Maternal insulin can cross the placenta</span></span></span></span></p>"
        },
        {
          "id": 53368,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The fetus starts secreting insulin at 12 weeks</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">All are true regarding physiology of pregnancy except?</span></span></span></p>",
      "unique_key": "Q8357193",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590773,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. C. Maternal insulin can cross the placenta</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Carbohydrate metabolism in pregnancy</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pregnancy is a diabetogenic state associated with hyperinsulinemia and insulin resistance</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Insulin resistance is due to placental hormones (human placental lactogen, estrogen, progesterone, cortisol)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Insulin secretion increases during pregnancy</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Insulin resistance is maximum between 24-28 weeks of pregnancy</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Maternal insulin cannot cross the placenta</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The fetus starts secreting insulin by 12 weeks</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s explore each of the given options:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin Secretion Increases in Pregnancy (Option A)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: True. During pregnancy, the body&#39;s need for insulin increases due to the greater demand for glucose by both the mother and the growing fetus. The pancreas typically responds by increasing insulin production to meet these needs.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin Resistance is Due to Placental Hormones (Option B)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This statement is also true. Pregnancy is characterized by a state of insulin resistance, which worsens as pregnancy progresses. This insulin resistance is primarily driven by placental hormones such as human placental lactogen, progesterone, and others. These hormones ensure that enough glucose is available for the fetus by making the mother&#39;s body less responsive to insulin.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal Insulin Can Cross the Placenta (Answer C)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is false, and therefore the correct answer. Maternal insulin does not cross the placenta. The fetus produces its own insulin starting from around 10-12 weeks of gestation. The mother&#39;s insulin does not enter the fetal circulation; instead, the glucose crosses the placenta, and the fetus produces insulin in response to this glucose.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Fetus Starts Securing Insu lin at 12 Weeks (Option D)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a true statement. The fetal pancreas begins to function and produce insulin around the 12th week of gestation. Fetal insulin plays a crucial role in fetal growth and development, especially in the second and third trimesters.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In pregnancy, there is an increase in insulin secretion due to increased insulin resistance, largely driven by placental hormones. However, maternal insulin does not cross the placenta; the fetus produces its own insulin in response to glucose that crosses from the maternal circulation. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page 66, William&rsquo;s Obstetrics 25<sup>th</sup> edition</span></span></span></strong></p>",
      "correct_choice_id": 53367,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13354,
      "choices": [
        {
          "id": 53377,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Maternal hyperglycemia leads to fetal hyperglycemia resulting in fetal hyperinsulinemia and related complications</span></span></span></span></p>"
        },
        {
          "id": 53378,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Maternal insulin can cross the placenta resulting in neonatal hypoglycemia</span></span></span></span></p>"
        },
        {
          "id": 53379,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Maternal hyperglycemia results in an increased incidence of congenital anomalies</span></span></span></span></p>"
        },
        {
          "id": 53380,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Fetal hyperinsulinemia results in a lower incidence of respiratory distress syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pederson&rsquo;s hypothesis states that: </span></span></span></span></p>",
      "unique_key": "Q6504783",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590774,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A. Maternal hyperglycemia leads to fetal hyperglycemia resulting in fetal hyperinsulinemia and related complications.</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s look at each option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal Hyperglycemia Leading to Fetal Hyperglycemia and Fetal Hyperinsulinemia (Answer A)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is true. &nbsp;Pederson&#39;s hypothesis primarily states that maternal hyperglycemia leads to fetal hyperglycemia, as glucose crosses the placenta. In response to this excess glucose, the fetal pancreas produces more insulin. This overproduction of insulin can lead to several complications in the fetus, such as macrosomia, increased risk of birth injuries, and neonatal hypoglycemia after birth.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal Insulin Crossing the Placenta Resulting in Neonatal Hypoglycemia (Option B)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. Insulin, being a large molecule, does not cross the placenta. Therefore, maternal insulin levels do not directly affect the fetus. The hypoglycemia seen in neonates of diabetic mothers is typically due to the baby&#39;s own insulin response to high glucose levels in utero.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal Hyperglycemia Results in Increased Incidence of Congenital Anomalies (Option C)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While this statement is true, it is not what Pederson&#39;s hypothesis is about. Poorly controlled diabetes in the mother can increase the risk of various congenital anomalies in the fetus, particularly if the hyperglycemia occurs during the critical first trimester of organogenesis.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal Hyperinsulinemia Results in a Lower Incidence of Respiratory Distress Syndrome (Option D)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option is incorrect. In fact, infants of diabetic mothers, especially those with poor glycaemic control, are at an increased risk of respiratory distress syndrome. This is due to delayed lung maturity, partly influenced by insulin&#39;s antagonistic effect on surfactant production.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pederson&#39;s hypothesis emphasizes the direct impact of maternal hyperglycemia on the fetus, leading to fetal hyperglycemia and resultant fetal hyperinsulinemia.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;This cascade underscores the importance of strict glycemic control in pregnant women with diabetes to prevent fetal complications, including macrosomia, birth injuries, and neonatal hypoglycemia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-100917.jpg\" style=\"height:828px; width:968px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 1102, Williams Obstetrics 25<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 53377,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13421,
      "choices": [
        {
          "id": 53645,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Consider termination of pregnancy</span></span></span></span></p>"
        },
        {
          "id": 53646,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Oral Acyclovir, antipyretics, and hydration</span></span></span></span></p>"
        },
        {
          "id": 53647,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">IV Acyclovir</span></span></span></span></p>"
        },
        {
          "id": 53648,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Varicella Zoster Immunoglobulin (VZIG)</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">A 24-year G2P1L1 teacher presents at 22 weeks with fever and rash since 2 days. She gives history of contact with a child in her class who had chicken pox 10 days earlier. What is the next best step in management? </span></span></span></span></p>",
      "unique_key": "Q9993027",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590784,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B. Oral Acyclovir, antipyretics, and hydration</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Chickenpox in Pregnancy </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">There are 2 important aspects to chicken pox in pregnancy:</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pregnant patient presents with rash (Chicken pox)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pregnant patient presents with contact with a person who has chicken pox, and is therefore at risk of developing chicken pox</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Scenario 1: Pregnant patient with rash i.e. she has already developed chicken pox</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Avoid contact with susceptible individuals, until the lesions have crusted over. This is usually about 5 days after the onset of the rash.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Symptomatic treatment and hygiene is advised to prevent secondary bacterial infection of the lesions.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Oral Acyclovir should be prescribed </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Intravenous Acyclovir should be given to all pregnant women with severe chickenpox. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">VZIG has no therapeutic benefit once chickenpox has developed</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Women who develop chickenpox in pregnancy should be referred to a fetal medicine specialist, at 16&ndash;20 weeks or 5 weeks after infection, for discussion and detailed ultrasound examination (Risk of congenital varicella)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">If maternal infection occurs in the last 4 weeks of a woman&rsquo;s pregnancy, there is a significant risk of varicella infection of the newborn. A planned delivery should normally be avoided for at least 7 days after the onset of the maternal rash to allow for the passive transfer of antibodies from mother to child. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Scenario 2: Pregnant patient with history of contact with a person who has chicken pox</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Determine if she has been vaccinated against chicken pox or has had the infection earlier (i.e. immunized)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">IF immunized, nothing further need be done</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">If not sure of status: Do IgG VZV</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">If IgG VZV is positive: she is immunized and nothing need be done</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">If she is IgG VZV negative or she is unimmunized: This means she is susceptible and should be given VZ IG within 10 days of contact. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\"><a href=\"https://www.rcog.org.uk/globalassets/documents/guidelines/gtg13.pdf\" style=\"color:blue; text-decoration:underline\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">https://www.rcog.org.uk/globalassets/documents/guidelines/gtg13.pdf</span></span></strong></a></span></span></span></p>",
      "correct_choice_id": 53646,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13349,
      "choices": [
        {
          "id": 53357,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Malformations</span></span></span></span></p>"
        },
        {
          "id": 53358,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Polyhydramnios</span></span></span></span></p>"
        },
        {
          "id": 53359,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Obesity</span></span></span></span></p>"
        },
        {
          "id": 53360,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Previous history of macrosomia</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Which is NOT seen in gestational diabetes mellitus?</span></span></span></span></p>",
      "unique_key": "Q1117456",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590769,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A. Malformations</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Congenital anomalies are NOT SEEN with GDM</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Congenital anomalies are seen Only with Overt DM</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">HbA1C &gt; 10 in the 1<sup>st</sup> trimester: Associated with a higher risk for congenital malformations</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Most Common system involved &ndash; cardiac</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Most common anomaly seen in GDM &ndash; VSD</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Most characteristic anomaly (very rare)&ndash; Mermaid syndrome/ sirenomelia</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let&#39;s briefly explain the other options:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Polyhydramnios:</span></strong><span style=\"font-size:12.0pt\"> Polyhydramnios refers to an excess of amniotic fluid in the amniotic sac during pregnancy. It can be a complication associated with GDM, as elevated blood sugar levels in the baby can lead to increased urine production, which, in turn, can contribute to polyhydramnios.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Obesity</span></strong><span style=\"font-size:12.0pt\">: Obesity is a risk factor for the development of GDM. Women who are overweight or obese before pregnancy are at a higher risk of developing GDM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Previous history of macrosomia</span></strong><span style=\"font-size:12.0pt\">: A previous history of giving birth to a macrosomic (large birthweight) baby is a risk factor for GDM. Macrosomia is a common outcome of GDM, and women who have previously experienced it are at an increased risk of developing GDM in subsequent pregnancies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gestational diabetes mellitus (GDM) is typically not associated with congenital malformations</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;GDM can lead to complications such as polyhydramnios, especially if blood sugar levels are uncontrolled during pregnancy.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Obesity is a risk factor for the development of GDM and a previous history of giving birth to a macrosomic baby increases the risk of GDM in subsequent pregnancies.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref:&nbsp; Page no 1110, Williams Obstetrics 25<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 53357,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13310,
      "choices": [
        {
          "id": 53201,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral antihypertensive therapy</span></p>"
        },
        {
          "id": 53202,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet transfusion</span></p>"
        },
        {
          "id": 53203,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnesium sulphate therapy and induction of labour</span></p>"
        },
        {
          "id": 53204,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous immunoglobulin therapy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 30-year-old primigravida woman presents at 29 weeks gestation with headache and a blood pressure of 160/110 mm Hg. Investigations reveal 2+ proteinuria on dipstick, an elevated SGOT and SGPT and a platelet count of 80,000/mm<sup>3</sup>. What is the best management?</span></p>",
      "unique_key": "Q2471162",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590786,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Magnesium sulphate therapy and induction of labour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Even if hemolysis is not established, thrombocytopenia and elevated liver enzymes point toward severe features in pre eclampsia, which needs to be treated with Magnesium sulphate therapy and induction of labour&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">HELLP syndrome is a complication of pre-eclampsia and includes</span><ul><li><span style=\"font-size:16px;\">Hemolysis</span></li><li><span style=\"font-size:16px;\">Elevated liver enzymes</span></li><li><span style=\"font-size:16px;\">Thromobocytopenia</span></li></ul></li><li><span style=\"font-size:16px;\">HELLP is an indication for termination of pregnancy.</span></li><li><span style=\"font-size:16px;\">MgSO4 also needs to be given for both seizure prophylaxis and will also provide neuro-protection of the neonate f/b delivery of the patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Severe features in pre eclampsia need to be started on magnesium sulphate therapy</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tuh4X1U.png\" width=\"1149\" height=\"607\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-134609.jpg\" alt=\"\" width=\"700\" height=\"926\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Contraindications to Conservative management in severe preeclampsia (This means deliver asap in the following scenarios):</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Remember by the mnemonic <strong>DELIVER Asap</strong></span></p><p><span style=\"font-size:16px;\">D: Fetal Distress</span></p><p><span style=\"font-size:16px;\">E: Eclampsia</span></p><p><span style=\"font-size:16px;\">L: HELLP</span></p><p><span style=\"font-size:16px;\">I: DIC</span></p><p><span style=\"font-size:16px;\">V: non-viable fetus (extremely preterm)</span></p><p><span style=\"font-size:16px;\">E: pulmonary Edema</span></p><p><span style=\"font-size:16px;\">R: Renal failure</span></p><p><span style=\"font-size:16px;\">Asap: Abruption</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Let's analyse each management option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Oral Antihypertensive Therapy: While</strong> managing high blood pressure is crucial in preeclampsia, this option alone does not address the other severe features of the condition like proteinuria, liver dysfunction, and thrombocytopenia.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Platelet Transfusion: In</strong> the context of preeclampsia, platelet transfusion is not typically a primary management strategy unless there's a risk of severe bleeding or if surgery (like cesarean section) is planned and the platelet count is critically low.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Magnesium Sulphate Therapy and Induction of Labour:</strong> This is the correct option. Given the severity of symptoms and the potential risks to both the mother and the fetus, management often involves delivery (the definitive treatment for preeclampsia), along with magnesium sulphate to prevent eclamptic seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Intravenous Immunoglobulin Therapy</strong>: IVIG is not a treatment for preeclampsia and does not address the immediate risks associated with this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In cases with severe features, like significant hypertension, proteinuria, liver dysfunction, and thrombocytopenia, the primary management is to stabilize the mother and expedite delivery, as the condition typically resolves only after delivery. Magnesium sulphate is essential for seizure prophylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Page no 1852, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13361,
      "choices": [
        {
          "id": 53405,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;<span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &lt; 95 mg/dL, 1h PP &lt; 140 mg/dL, 2h PP &lt; 120 mg/dL</span></span></span></span></p>"
        },
        {
          "id": 53406,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &lt; 90 mg/dl, 1h PP &lt; 145 mg/ dl, 2h &lt; 125 mg/dl</span></span></span></span></p>"
        },
        {
          "id": 53407,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &lt; 105 mg/dl, 1h PP &lt; 140 mg/dl, 2h PP &lt; 120 mg/dl</span></span></span></span></p>"
        },
        {
          "id": 53408,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &lt; 95 mg/dl, 1h PP &lt; 120 mg/ dl, 2h PP &lt; 140 mg/dl</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Target blood glucose levels for women with gestational diabetes on treatment are:</span></span></span></span></p>",
      "unique_key": "Q7753352",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590778,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A.&nbsp; FBS &lt; 95 mg/dL, 1h PP &lt; 140 mg/dL, 2h PP &lt; 120 mg/dL</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The target blood glucose levels in treatment of diabetes in pregnancy is:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &lt; 95 mg/dL</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&nbsp;1h PP &lt; 140 mg/dL</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&nbsp;2h PP &lt; 120 mg/dL</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These targets are designed to balance the need for tight glucose control to prevent fetal complications while minimizing the risk of maternal hypoglycemia. It&#39;s important for women with gestational diabetes to monitor their blood glucose levels regularly and adhere to their treatment plan, which may include diet modifications, exercise, and possibly medication.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For the management of gestational diabetes, target blood glucose levels are set to ensure both maternal and fetal well-being. The recommended targets are:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;fasting blood sugar less than 95 mg/dL</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-hour postprandial less than 140 mg/dL</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2-hour postprandial less than 120 mg/dL. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 264, DC Dutta&rsquo;s Textbook of Obstetrics 9<sup>th</sup> edition</span></span></span></strong></p>",
      "correct_choice_id": 53405,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13363,
      "choices": [
        {
          "id": 53413,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&gt; 4000g</span></span></span></span></p>"
        },
        {
          "id": 53414,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&gt; 4500g</span></span></span></span></p>"
        },
        {
          "id": 53415,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&gt; 5000g</span></span></span></span></p>"
        },
        {
          "id": 53416,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&gt; 5500g</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Elective cesarean delivery is indicated in a diabetic woman if the estimated fetal weight is</span></span></span></p>",
      "unique_key": "Q3470343",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590780,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B. &gt; 4500g</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">As per the ACOG (to prevent shoulder dystocia)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Elective LSCS is done in non-diabetic women if the estimated fetal weight is &gt; 5kg</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Elective LSCS is done in diabetic women if the estimated fetal weight is &gt; 4.5kg</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The increased risk in diabetic pregnancies is attributed to the higher incidence of fetal macrosomia, often a result of poorly controlled maternal blood glucose levels. Macrosomia increases the risk of complications during vaginal delivery, including shoulder dystocia, where the baby&#39;s shoulder becomes lodged behind the mother&#39;s pelvic bone during delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per ACOG, for diabetic pregnant women, an elective cesarean delivery is recommended if the estimated fetal weight exceeds 4.5 kg. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is in contrast to non-diabetic women, where the threshold for an elective cesarean is set at an estimated fetal weight of more than 5 kg. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The lower threshold for diabetic women is due to the increased risk of macrosomia and related birth complications, including shoulder dystocia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page 859, Williams Obstetrics 25<sup>th</sup> edition</span></span></span></strong></p>",
      "correct_choice_id": 53414,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}